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all rectum applicators. Simulations in patients 3DCT scan 
allowed us to evaluate CXRT dose to organs at risk and to the 
target volume. The comparison of dosimetric indices of EBRT 
and CXRT treatment delivery for the high risk target volume 
showed that the CXRT technique delivers higher dose to the 
target volume for the same dose, or even less for some cases, 
to the organs at risk. 
 
Conclusion: Monte-Carlo simulations are useful to compute 
accurate dose distributions in 3DCT patient data for the CXRT 
treatment delivery. Moreover, this comparative study 
between the EBRT and CXRT techniques confirms the role of 
CXRT in curative treatment with organ preservation for early 
rectal cancers. 
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Purpose or Objective: In previous studies the dosimetric 
impact of an implanted rectum spacer (IRS) in prostate 
cancer patients undergoing intensity-modulated radiation 
therapy (IMRT) has been assessed by dose-volume histograms 
(DVHs) and dose-surface histograms (DSHs) obtained from 3D 
dose distributions of the ano-rectal wall (ARW). 
Unfortunately, spatial information is lost when analyzing 
DVHs or DSHs. This hampers to study the correlation between 
the shape and location of the ARW dose distribution and 
clinical outcome. Dose-surface maps (DSMs) have been 
suggested as a valuable tool for taking the spatial-dosimetric 
information into account.The purpose of this study is to 
assess spatio-dosimetric differences in DSMs obtained from 
planned ARW dose distributions in patients receiving IMRT 
with and without IRS (IMRT+IRS; IMRT-IRS, respectively). 
 
Material and Methods: In 26 patients with localized prostate 
cancer a hydrogel rectum spacer (SpaceOAR®, Augmenix) was 
injected under transrectal ultrasound guidance in 
Denonvilliers’ space between the prostate and the rectal 
wall. Per patient, two IMRT treatment plans (78 Gy in 39 
fractions) were designed, based on CT scans acquired before 
and after hydrogel injection. DSMs of the ARW were 
generated from the planned 3D dose distributions by virtual 
unfolding the rectum contour as described in Buettner et al. 
(Fig. 1a-b).  
 
 
Various shape-based dose measures were extracted from the 
DSMs. First, dose clusters were generated by thresholding the 
DSMs at 38 dose levels ranging from 5-79 Gy. Then, for each 
dose level an ellipse was fitted to the largest dose cluster. 
Lateral (posterior-anterior-posterior) and longitudinal 
(superior-inferior) extents were quantified by projecting the 
major and minor axes of this ellipse to the main axes of the 
DSMs. The non-circularity of the dose clusters was described 
by the eccentricity of the ellipse. The contiguity of the ARW 
dose distribution was assessed by the contiguous-DSH (cDSH), 
reflecting the single largest contiguous ARW area fraction as 
function of the dose threshold at the given level. Statistical 
differences were assessed with a one-sided paired Wilcoxon 
signed rank test. 
 
Results: Lateral extent, longitudinal extent as well as cDSH 
were significantly lower in IMRT+IRS than for IMRT-IRS at 
high-dose levels. Largest significant differences were 
observed for cDSH at dose levels >50Gy, followed by lateral 
extent at doses >57Gy, and longitudinal extent. For these 
three features, no significant differences were observed for 
low to medium dose levels. For eccentricity no significant 
differences were found, independent of the dose level. 
 
Conclusion: Significant spatio-dosimetric differences in ARW 
DSMs exist between prostate cancer patients undergoing IMRT 
with and without IRS. The IRS particularly reduces the lateral 
and longitudinal extent of high-dose areas (>50 Gy) in 
anterior and superior-inferior directions. 
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Purpose or Objective: SBRT is a novel treatment procedure, 
which is used for the particular localization of the tumor to 
deliver targeted high doses with greatly precise fields. 
Different irradiation techniques provide a wide spectrum of 
therapy options. The aim of this work was to evaluate the 
clinical benefits and potential dosimetric of different 
planning methods against each other for the treatment of 
NSCLC. 
 
Material and Methods: In this study, three diagnosed 
patients with NSCLC metastasis, were chosen. One had a 
peripheral metastasis in the left lung , the other had a 
metastasis in the right lung, and the last one had a central 
metastasis located near to vertebral body. The delineated 
structures (PTV and OARs) on CT were shared among 22 
clinics with the request to generate an irradiation plan with 
their own internal criteria. Three fractions of 15 Gy were 
prescribed to the PTV-enclosing 65%. All together it was 
